Transfer and nontransfer patients in isolated low-grade blunt pediatric solid organ injury: Implications for

Robert A Tessler1, Vivian H Lyons, Judith C Hagedorn

  • 1From the Department of Surgery (R.A.T.), UCSF East Bay, Oakland, California; Harborview Injury Prevention and Research Center (R.A.T., V.H.L., J.C.H., M.S.V., S.A., F.P.R); Department of Surgery (R.A.T., A.G., S.A.), Department of Epidemiology (V.H.L., F.P.R.), Department of Urology (J.C.H.), Department of Anesthesiology and Pain Medicine (M.S.V.), University of Washington; Division of Pediatric General and Thoracic Surgery (A.G.), Seattle Children's Hospital; Department of Surgery, Division of Trauma, Burns, and Critical Care (S.A.), and Department of Pediatrics (F.P.R.), University of Washington, Seattle, Washington.

Insights

Pediatric patients with isolated low-grade blunt solid organ injuries often do not require surgery and may not need transfer to a higher level trauma center. Revising transfer policies can prevent unnecessary transfers and reduce costs in pediatric trauma care.

Area of Science:

  • Pediatric Surgery
  • Trauma Care
  • Public Health

Background:

  • Regionalization of trauma care is a national priority.
  • Hospitalization for blunt abdominal trauma is common in children, often involving transfers.
  • Understanding care variations for pediatric blunt abdominal trauma is crucial.

Purpose of the Study:

  • To compare outcomes for pediatric patients with blunt abdominal trauma based on transfer status and trauma center level.
  • To determine differences in mortality, treatment, and length of stay.
  • To inform trauma system policies regarding patient transfers.

Main Methods:

  • Retrospective cohort study using the Washington state trauma registry (2000-2014).
  • Included patients 16 years or younger with isolated Grade I-III spleen, liver, or kidney injury.
  • Compared outcomes for patients treated at lower-level trauma centers versus those transferred to higher-level centers.

Main Results:

  • Of 1177 pediatric patients with low-grade solid organ injuries, 226 went to higher-level centers, 600 stayed at lower-level centers, and 351 were transferred.
  • No significant difference in surgery risk between transferred and non-transferred patients initially at lower-level centers.
  • Non-transferred patients had a significantly shorter hospital stay compared to transferred patients.
  • One death occurred among all patients.

Conclusions:

  • Pediatric patients with isolated low-grade blunt solid organ injuries rarely require intervention and may not need transfer.
  • Trauma systems should re-evaluate and revise transfer policies for these patients.
  • Reducing unnecessary transfers offers potential cost savings in pediatric trauma care.
Abstract

Related Concept Videos

Types of Genetic Transfer Between Organisms02:18

Types of Genetic Transfer Between Organisms

Genetic transfer occurs when genetic information is passed from one organism to another. It occurs via two mechanisms: vertical gene transfer and horizontal gene transfer. Vertical gene transfer occurs when genetic information is transferred from one generation to the next, which happens much more frequently than horizontal gene transfer. Both sexual and asexual reproduction are forms of vertical gene transfer, where one or more organisms pass some or all of their genome onto their progeny.
31.2K
Types of Genetic Transfer Between Organisms02:18

Types of Genetic Transfer Between Organisms

6.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
281
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Transfer Function in Control Systems01:21

Transfer Function in Control Systems

The transfer function is a fundamental concept in the analysis and design of linear time-invariant (LTI) systems. It offers a concise way to understand how a system responds to different inputs in the frequency domain. It serves as a bridge between the time-domain differential equations that describe system dynamics and the frequency-domain representation that facilitates easier manipulation and analysis.
To derive the transfer function, consider a general nth-order linear time-invariant...
1.6K